SuperNova v428: New Bright Polymer Dye for Flow Cytometry
Arunkumar Easwaran, Massimiliano Tomasulo, Boi Hoa San, Mukesh Mudgal, Sergei Gulnik | Beckman Coulter Inc., Miami, FL, USA
Valérie Mallet Designe, Sylvain Monseaux | Beckman Coulter, Marseille, France
Introduction to SuperNova v428
SuperNova v428 is a new violet laser (405 nm)-excitable water-soluble polymer dye which shows exceptional brightness. This is attributed to its high extinction coefficient (~3 million Lmol-1 cm-1) and fluorescence quantum yield (~0.6) in phosphate buffer. Excitation maximum of this polymer is measured as 414 nm and its emission maximum is at 428 nm (Figure 1) which can be detected using a 450/50 bandpass filter or equivalent in a flow cytometer.
| Figure 1: (Left) Absorption and emission spectra (λexc = 405 nm) of SuperNova v428 in PBS. (Right) SuperNova v428 solution in PBS upon illumination using a UV lamp at 365 nm. |
Synthesis of SuperNova Polymer dyes and conjugation to Antibodies
SuperNova v428 dye is prepared by polymerization of water-soluble monomers as shown in Figure 2 which leads to formation of a highly conjugated fluorescent backbone. Capping is carried out on the polymer followed by activation using appropriate functionalities, resulting in polymer capable of conjugation to antibodies. These activated polymers conjugated to antibodies followed by purification using a standardized procedure.
| Figure 2: Schematic procedure for SuperNova v428 polymer synthesis, activation and conjugation process. |
Polymer dye conjugates usually tend to generate significant non-specific staining, for instance by binding nonspecifically to cells expressing Fc receptors such as monocytes. A proprietary formulation has been identified and optimized to minimize this non-specific staining, allowing to further improve stain index of SuperNova v428.
| Figure 3: CD22-SNv428 whole blood staining before (left) and after (right) formulation with additives preventing non specific staining. Background on monocytes is significantly reduced. |
Flow Cytometry results
SuperNova v428 was conjugated to dierent antibodies and compared with PE, Pacific Blue and Brilliant Violet polymer dye conjugates. Antibody-SuperNova v428 conjugates exhibited more than 10 times the brightness of Pacific Blue and also better brightness than PE and BV 421 in flow cytometry. Nonspecific staining was also significantly reduced compared to BV 421 conjugates.
| Figure 4: SuperNova v428 conjugates (with CD19, CD22, and CD25) compared against conjugates of BV421, PE and Pacific Blue in flow cytometry. All SuperNova v428 conjugates showed higher brightness to above mentioned commercially available conjugates. Nonspecific binding significantly reduced in the case of SuperNova v428 conjugates. |
| Lymphocytes Stain Index |
Monocytes MFI (background) |
||
|---|---|---|---|
| CD19 | SN v428 | 281 | 0.688 |
| BV421 | 191 | 1.533 | |
| PE | 246 | 0.805 | |
| Pacific Blue | 48 | 0.600 | |
| CD22 | SN v428 | 172 | 1.033 |
| BV421 | 123 | 1.476 | |
| PE | 136 | 0.716 | |
| Pacific Blue | 28 | 0.958 | |
| CD25 | SN v428 | 36 | 0.731 |
| BV421 | 14 | 2.021 | |
| PE | 24 | 1.052 | |
| Pacific Blue | 6 | 0.522 |
| Table 1: Lymphocytes staining index and monocytes MFI (background) obtained staining normal whole blood with lymphocytes markers conjugated to SN v428, BV421, PE and Pacific Blue. |
Conclusion
SuperNova polymer dyes are a new generation of polymer dyes for flow cytometry application. SuperNova v428 has unique photo-physical properties leading to extremely bright conjugates when conjugated to antibodies. A proprietary formulation leveraging unique additives allows to minimize non-specific staining for greater confidence in flow cytometry staining results and improved staining index. Therefore SuperNova v428 conjugates are particularly suited for the study of low abundance and dimly expressed markers.
For Research Use Only – Not for use in diagnostic procedures.
Pacific Blue is a registered trademark of Molecular Probes, Inc.
Helpful links
-
Reactivos de citometría de flujo
- superRCA® MRD Assays
-
Anticuerpos y kits
-
Anticuerpos de un solo color
- Explore Single Color Antibodies by specificity
- Controles de isotipo
- Panel Design
- Product Listings and Catalogs
- Estándares de calidad
- Antígeno APO2.7 (7A6)
- Antígeno de microglobulina beta2
- Antígeno CD10
- Antígeno CD103
- Antígeno CD105
- Antígeno CD106
- Antígeno CD107a (LAMP-1)
- Antígeno CD109 (E123)
- Antígeno CD116 (GM-CSFR)
- Antígeno CD117 (c-kit)
- Antígeno CD11a
- Antígeno CD11b
- Antígeno CD11c
- Antígeno CD122 (IL-2Rß)
- Antígeno CD123 (IL-3Rα)
- Antígeno CD126 (IL-6Rα)
- Antígeno CD127 (IL-7Rα)
- Antígeno CD13
- Antígeno CD133
- Antígeno CD134 (OX 40)
- Antígeno CD135 (flt3/flk2)
- Antígeno CD137
- Antígeno CD138
- Antígeno CD141 (BDCA-3)
- Antígeno CD14
- Antígeno CD144 (VE-cadherina)
- Antígeno CD146
- Antígeno CD15
- Antígeno CD152 (CTLA-4)
- Antígeno CD154
- Antígeno CD157
- Antígeno CD158a,h
- Antígeno CD158b1/b2,j
- Antígeno CD158e1/e2
- Antígeno CD158f (KIR2DL5)
- Antígeno CD158i
- Antígeno CD159a
- Antígeno CD16
- Antígeno CD160
- Antígeno CD161 (NKR-P1A)
- Antígeno CD166 (ALCAM)
- Antígeno CD18
- Antígeno CD180
- Antígeno CD183 (CXCR3)
- Antígeno CD184 (CXCR4)
- Antígeno CD19
- Antígeno CD196 (CCR6)
- Antígeno CD197 (CCR7)
- Antígeno CD1a
- Antígeno CD1c
- Antígeno CD2
- Antígeno CD20
- Antígeno CD200
- Antígeno CD203c
- Antígeno CD206 (MMR)
- Antígeno CD207 (langerina)
- Antígeno CD208 (DC-LAMP)
- Antígeno CD209 (DC-SIGN)
- Antígeno CD21
- Antígeno CD22
- Antígeno CD23
- Antígeno CD23
- Antígeno CD235a (glicoforina A)
- Antígeno CD24
- Antígeno CD243 (glicoproteína P)
- Antígeno CD244 (2B4)
- Antígeno CD25
- Antígeno CD26
- Antígeno CD27
- Antígeno CD274 (PD-L1)
- Antígeno CD278 (ICOS)
- Antígeno CD279 (PD-1)
- Antígeno CD28
- Antígeno CD29
- Antígeno CD294 (CRTH2)
- Antígeno CD3
- Antígeno CD30
- Antígeno CD300a (IRp60)
- Antígeno CD305 (LAIR1)
- Antígeno CD309 (KDR)
- Antígeno CD31
- Antígeno CD314 (NKG2D)
- Antígeno CD32
- Antígeno CD326 (EpCAM)
- Antígeno CD328 (p75 AIRM1)
- Antígeno CD33
- Antígeno CD335 (NKp46)
- Antígeno CD336 (NKp44)
- Antígeno CD337 (NKp30)
- Antígeno CD34
- Antígeno CD35
- Antígeno CD352 (NTB-A)
- Antígeno CD36
- CD366 (TIM-3) Antibodies
- Antígeno CD37
- Antígeno CD370 (Clec9A)
- Antígeno CD38
- CD38(VHH) Antibodies
- Antígeno CD39
- Antígeno CD4
- Antígeno CD40
- Antígeno CD41
- Antígeno CD42a
- Antígeno CD42b
- Antígeno CD43
- Antígeno CD44
- Antígeno CD45
- Antígeno CD45RA
- Antígeno CD45RO
- Antígeno CD48
- Antígeno CD49b
- Antígeno CD49d
- Antígeno CD49e
- Antígeno CD5
- Antígeno CD52
- Antígeno CD54
- Antígeno CD55
- Antígeno CD56
- Antígeno CD57
- Antígeno CD58
- Antígeno CD59
- Antígeno CD6
- Antígeno CD61
- Antígeno CD62L
- Antígeno CD62P
- Antígeno CD63
- Antígeno CD64
- Antígeno CD65
- Antígeno CD66b
- Antígeno CD66c (KOR-SA3544)
- Antígeno CD69
- Antígeno CD7
- Antígeno CD71
- Antígeno CD73
- Antígeno CD79a
- Antígeno CD79b
- Antígeno CD8
- Antígeno CD80
- Antígeno CD81
- Antígeno CD83
- Antígeno CD85d (ILT4)
- Antígeno CD85j (ILT2)
- Antígeno CD85k (ILT3)
- Antígeno CD86
- Antígeno CD8β
- Antígeno CD9
- Antígeno CD90
- Antígeno CD94
- Antígeno CD95
- Antígeno CD99
- Antígeno ciclina A2
- Antígeno citoqueratina
- Antígeno DAP12 (DNAX/KARAP/TYROBP)
- Antígeno FMC7 (CD20)
- Antígeno FoxP3
- Antígeno grancima B
- Antígeno Helios
- Antígeno central del VIH-1
- Antígeno HLA-ABC
- Antígeno HLA-DQ
- Antígeno HLA-DR
- Antígeno HLA-DR, DP, DQ
- Antígeno del IFN-γ
- Antígeno de la IgD
- Antígeno de la IgE (Dε2)
- Antígeno de la IgM
- Antígeno de la IL-17A
- Antígeno de la IL-2
- Antígeno de la IL-4
- Antígeno de cadena kappa
- Antígeno Ki-67
- Antígeno de lactoferrina
- Antígeno de cadena lambda
- Antígeno de la mieloperoxidasa
- Antígeno NG2 (7.1)
- Antígeno NKp80
- Antígeno OSCAR
- Antígeno de la perforina
- Antígeno ROR1
- Antígeno RLT PAN α/β
- Antígeno RLT PAN γ/δ
- Antígeno RLT Vα7.2
- Antígeno RLT Vα24
- Antígeno RLT Vβ1
- Antígeno RLT Vβ2
- Antígeno RLT Vβ3
- Antígeno RLT Vβ4
- Antígeno RLT Vβ5.1
- Antígeno RLT Vβ5.2
- Antígeno RLT Vβ5.3
- Antígeno RLT Vβ7.1
- Antígeno RLT Vβ7.2
- Antígeno RLT Vβ8
- Antígeno RLT Vβ9
- Antígeno RLT Vβ11
- Antígeno RLT Vβ12
- Antígeno RLT Vβ13.1
- Antígeno RLT Vβ13.2
- Antígeno RLT Vβ13.6
- Antígeno RLT Vβ14
- Antígeno RLT Vβ16
- Antígeno RLT Vβ17
- Antígeno RLT Vβ18
- Antígeno RLT Vβ20
- Antígeno RLT Vβ21.3
- Antígeno RLT Vβ22
- Antígeno RLT Vβ23
- Antígeno VCR Vδ1
- Antígeno VCR Vδ2
- Antígeno RLT Vγ9
- Antígeno RLT ζ
- Antígeno TdT
- Antígeno del receptor de trombina
- Antígeno TIA-1
- Antígeno FNT alfa
- TRBC1 Antibodies
- TRBC2 Antibodies
- Antígeno ZAP-70
- Combinados de anticuerpos de 2 a 4 colores
- Single-Color Antibodies new
- Reactivos AQUIOS
- Soluciones de anticuerpos ClearLLab
-
Perfiles DURAClone
- DURAClone Antibody Panel Technology
- DURAClone Dry Antibody Panels for Immune System research
- DURAClone Dry Antibody Panels for Immune Function research
- DURAClone Dry Antibody Panels for Rare Event Detection
- DURAClone Dry Antibody Panels for the Characterization of Human Adult Stem Cells
- DURAClone IM Count
- DURAClone IM Phenotyping Basic
- DURAClone IM T Cell Subsets
- DURAClone IM Treg
- DURAClone IM TCRs
- DURAClone IM B Cell
- DURAClone IM Dendritic Cell
- DURAClone IM Granulocytes
- DURAClone IM Innate Lymphoid Cell Tube
- DURAClone IF T Cell Activation
- DURAClone IF T Helper Cell
- DURAClone IF Monocyte Activation
- DURAClone IF Basophil Activation
- DURAClone IF NK Activation Tube
- DURAClone RE AML
- DURAClone RE CLB
- DURAClone RE PC
- DURAClone RE ALB
- DURAClone RE CTC
- DURAClone RE CTC PerFix CTC
- DURAClone SC Mesenchymal Stem Cell
- DURAClone SC Hematopoietic Stem Cell
- Kits de estimulación DURActive
- Sistemas y kits clínicos/de investigación clínica
-
Anticuerpos de un solo color
-
Ensayos de investigación y salud celular
- Principio de ensayo por citometría de flujo del ciclo celular
- Flujo de trabajo optimizado para el análisis de ciclo celular
- Análisis avanzado del ciclo celular
- Espectro del yoduro de propidio
- Rendimiento del kit de ciclo celular
-
Colorantes de viabilidad fijable ViaKrome
- Comparación de reactivos a base de éster NHS con el colorante de viabilidad fijable ViaKrome
- Comparison_NEW
- Flexibilidad para diseño de paneles multicolor
- Flexibility for Multicolor Panel Design_NEW
- Rendimiento sólido
- Performance_NEW
- Protocolo de tinción del colorante de viabilidad fijable ViaKrome
- Staining Protocol_NEW
- ¿Por qué utilizar un colorante de viabilidad?
- Why_NEW
- Colorantes de unión de ADN
- Reactivos de apoptosis
- Ensayos de investigación
- Infrared Fluorescent Dyes
- Colorantes de polímero fluorescente SuperNova
- Reactivos de lisado, fijado y permeabilización
- Fluoroesferas y control de calidad
- Servicios de reactivos personalizados



